SEGMENTS (Details)	3 Months Ended				6 Months Ended
	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Jun. 30, 2022 USD ($) Facility	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Segment Reporting Information [Abstract]
Number of plasma collection facilities | Facility					10
Number of FDA-licensed plasma collection facilities | Facility					6
Number of additional plasma collections centers in operation and collection of plasma | Facility					2
Number of remaining plasma collection facilities under construction | Facility					2
Revenues	$ 33,905,007		$ 17,830,590		$ 63,008,100	$ 33,879,208
Cost of product revenue	26,135,614		18,832,624		51,576,660	36,602,746
Loss from operations	(9,174,739)		(15,581,232)		(23,989,805)	(30,745,481)
Interest and other expense, net	(4,590,167)		(3,324,071)		(8,113,017)	(6,539,763)
Loss on extinguishment of debt	0		0		(6,669,941)	0
Net loss	(13,764,906)	$ (25,007,857)	(18,905,303)	$ (18,379,941)	(38,772,763)	(37,285,244)
Capital expenditures					6,782,169	7,046,735
Total assets	296,932,329		232,813,792		296,932,329	232,813,792	$ 276,252,724
Depreciation and amortization expense	1,724,283		1,325,994		3,314,500	2,555,622
United States [Member]
Segment Reporting Information [Abstract]
Revenues	31,274,844		15,424,839		58,590,995	29,102,848
International [Member]
Segment Reporting Information [Abstract]
Revenues	2,630,163		2,405,751		4,417,105	4,776,360
Corporate [Member]
Segment Reporting Information [Abstract]
Revenues	35,709		35,709		71,417	71,417
Cost of product revenue	0		0		0	0
Loss from operations	(4,708,692)		(4,449,608)		(11,385,373)	(8,137,328)
Interest and other expense, net	(4,572,035)		(3,244,912)		(8,044,889)	(6,438,706)
Loss on extinguishment of debt					(6,669,941)
Net loss	(9,280,727)		(7,694,520)		(26,100,203)	(14,576,034)
Capital expenditures					0	0
Total assets	42,800,955		42,420,872		42,800,955	42,420,872
Depreciation and amortization expense	155		1,530		918	3,397
Operating Segments [Member] | ADMA BioManufacturing [Member]
Segment Reporting Information [Abstract]
Revenues	32,120,119		16,347,880		57,848,744	29,768,923
Cost of product revenue	24,287,122		17,382,292		46,500,902	32,832,049
Loss from operations	(445,248)		(8,337,405)		(4,720,538)	(17,843,093)
Interest and other expense, net	(17,796)		(78,793)		(67,062)	(100,307)
Loss on extinguishment of debt					0
Net loss	(463,044)		(8,416,198)		(4,787,600)	(17,943,400)
Capital expenditures					2,584,906	2,725,432
Total assets	220,052,465		169,799,509		220,052,465	169,799,509
Depreciation and amortization expense	1,159,732		1,055,537		2,271,683	2,065,307
Operating Segments [Member] | Plasma Collection Centers [Member]
Segment Reporting Information [Abstract]
Revenues	1,749,179		1,447,001		5,087,939	4,038,868
Cost of product revenue	1,848,492		1,450,332		5,075,758	3,770,697
Loss from operations	(4,020,799)		(2,794,219)		(7,883,894)	(4,765,060)
Interest and other expense, net	(336)		(366)		(1,066)	(750)
Loss on extinguishment of debt					0
Net loss	(4,021,135)		(2,794,585)		(7,884,960)	(4,765,810)
Capital expenditures					4,197,263	4,321,303
Total assets	34,078,909		20,593,411		34,078,909	20,593,411
Depreciation and amortization expense	$ 564,396		$ 268,927		$ 1,041,899	$ 486,918